Candy Smellie, profile picture

Candy Smellie

22 Slideshow
Sort by
Blueprints to blue sky – analyzing the challenges and solutions for IHC companion diagnostics
porCandy Smellie
 
Understanding and controlling for sample and platform biases in NGS assays
porCandy Smellie
 
Resolving Ambiguity in Target ID Screens - CRISPR-Cas9 Based Essentiality Profiling
porCandy Smellie
 
Molecular QC: Interpreting your Bioinformatics Pipeline
porCandy Smellie
 
Identification and Prioritization of Drug Combinations for Treatment of Cancer
porCandy Smellie
 
Molecular QC: Using Reference Standards in NGS Pipelines
porCandy Smellie
 
Improving Immunohistochemistry Standardization in your Laboratory: Renewable Reproducible and Consistent Reference Standards
porCandy Smellie
 
Cell Free DNA comes to the Clinic
porCandy Smellie
 
Genome Editing Comes of Age; CRISPR, rAAV and the new landscape of molecular cell biology
porCandy Smellie
 
Addressing the Pre-PCR Analytical Variability of FFPE Samples
porCandy Smellie
 
Using reference materials to meet validation & verification requirements for clinical laboratory procedures
porCandy Smellie
 
Genome Editing Comes of Age
porCandy Smellie
 
CRISPR: Gene editing for everyone
porCandy Smellie
 
RNA-based screening in drug discovery – introducing sgRNA technologies
porCandy Smellie
 
To assess the effect of formalin on genomic DNA and assay performance for somatic variant detection
porCandy Smellie